sub-Saharan Africa

Open Access | Decreasing childhood mortality and increasing proportion of malaria deaths in rural Burkina Faso

Author(s):

Heribert Ramroth1*§, Robert P. Ndugwa1§, Olaf Mu¨ ller1, Yazoume Ye´ 2, Ali Sie´ 3, Bocar Kouyate´ 4 and Heiko Becher1

Reference:

Global Health Action 2009

The aim of this study was to describe temporal trends for malaria and all-cause mortality by combining a series of clinical and intervention studies conducted in Burkina Faso.

Person:

Country:

Region:

Medical Condition:

Special Focus Review: From the circumsporozoite protein to the RTS,S/AS candidate vaccine

Tags:

malaria

Author(s):

Joe Cohen, Victor Nussenzweig, Johan Vekemans and Amanda Leach

Reference:

Human Vaccines, Volume 6, Issue 1, January 2010

The RTS,S/AS01E malaria vaccine candidate has recently entered phase 3 testing. Reaching this important milestone is the culmination of more than 20 years of research and development by GlaxoSmithKline and partners and collaborators. The vaccine has been developed to protect young children and infants living in sub-Saharan Africa against clinical and severe disease caused by Plasmodium falciparum infection.

Person:

Continent:

Region:

Medical Condition:

Medical Treatment: